retatrutide mechanism triple agonist gip glp-1 glucagon receptor A review of an investigational drug retatrutide, a novel agent for the treatment of obesity | European Journal of Clinical Pharmacology Frontiers | Mechanisms of action

doi: 10.1359/jbmr.2003.18.12.2180

The platform does not provide services to minors

doi:10.1152/ajpendo.00069.2016 Gupta NA, Mells J, Dunham RM, et al

That approach ignores medical history, mental health, reproductive goals, and the very real fact that these medications affect appetite, digestion, and nutrition status

Secondary searches were performed using Google Scholar and regulatory sources, e.g., US Food and Drug Administration (FDA) labels and European Medicines Agency (EMA) reports, to capture gray literature and pharmacovigilance data

3 4 , Biochemical Properties and Metabolism Allulose possesses distinctive metabolic characteristics that contribute to its therapeutic potential